Prevalence of germline BRCA mutations in HER2-negative metastatic breast cancer: global results from the real-world, observational BREAKOUT study

BACKGROUND: The global observational BREAKOUT study investigated germline BRCA mutation (gBRCAm) prevalence in a population of patients with human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer (MBC). METHODS: Eligible patients had initiated first-line cytotoxic chemothe...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Shaughnessy, Joyce, Brezden-Masley, Christine, Cazzaniga, Marina, Dalvi, Tapashi, Walker, Graham, Bennett, James, Ohsumi, Shozo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590609/
https://www.ncbi.nlm.nih.gov/pubmed/33109210
http://dx.doi.org/10.1186/s13058-020-01349-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590609/
https://www.ncbi.nlm.nih.gov/pubmed/33109210
http://dx.doi.org/10.1186/s13058-020-01349-9

Ejemplares similares